| JYSB2200111 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2022-06-30 | | | | | view |
| JYSB2300063 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2023-04-11 | | | | | view |
| JYSB2300197 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2023-11-14 | | | | | view |
| JYSB2300016 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2023-02-07 | | | | | view |
| JYSB2101061 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2021-06-25 | | | | | view |
| CXSS2300038 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products(3.3) | New Drug Application | 2023-05-24 | | Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group | | | view |
| JYSB2300009 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2023-01-17 | | | | | view |
| CXSL2101162 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products(3.3) | New Drug Application | 2021-06-29 | | CSPC Megalith Biopharmaceutical Co Ltd | | | view |
| CXSS2300002 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products(3.3) | New Drug Application | 2023-01-10 | | QILU Pharmaceutical Co Ltd | | | view |
| JYSB2101013 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2021-04-23 | | | | | view |
| JYSZ2300019 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | License Renew | 2023-04-21 | | | | | view |
| JXSL0800003 | 帕妥珠单抗注射剂 | pertuzumab | Injection | Biological Products | Import Drug Application | 2008-03-12 | F.Hoffmann-La Roche Ltd. | F Hoffmann-La Roche Ltd(Switzerland) | Certificate Issued | 2010-01-29 | view |
| JXSL1200006 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Import Drug Application | 2012-02-09 | F.Hoffmann-La Roche Ltd. | F Hoffmann-La Roche Ltd(Switzerland) | Certificate Issued | 2013-04-10 | view |
| JXSL1100038 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Import Drug Application | 2011-08-09 | F.Hoffmann-La Roche Ltd. | F Hoffmann-La Roche Ltd(Switzerland) | Certificate Issued | 2012-08-21 | view |
| JTS1900002 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Disposable Import Drug Application | 2019-01-22 | Roche Diagnostics GmbH | Roche Diagnostics GmbH | Certificate Issued | 2019-02-26 | view |
| CXSL1500030 | SHR-1309注射液 | pertuzumab | Injection | Biological Products(2) | New Drug Application | 2015-05-13 | 上海恒瑞医药有限公司 | Shanghai Hengrui Pharmaceutical Co Ltd | Certificate Issued | 2017-02-21 | view |
| JXSS1700018 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Import Drug Application | 2018-01-02 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd | Certificate Issued | 2018-12-19 | view |
| CXSL1700090 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products(2) | New Drug Application | 2017-10-18 | 正大天晴药业集团南京顺欣制药有限公司 | Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group | Certificate Issued | 2018-05-08 | view |
| JYSB1900363 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2020-01-19 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2020-03-24 | view |
| JYSB2000696 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2021-01-05 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2021-03-17 | view |
